Orencia and Hair loss - a phase IV clinical study of FDA data
Summary:
We study 124,994 people who have side effects when taking Orencia. Hair loss is found, especially among people who are female, 40-49 old, have been taking the drug for 6 - 12 months, also take Enbrel and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people take Orencia and have Hair loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
124,994 people reported to have side effects when taking Orencia.
Among them, 11,906 people (9.53%) have Hair loss.
What is Orencia?
Orencia has active ingredients of abatacept. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 125,317 Orencia users.
What is Hair loss?
Hair loss is found to be associated with 3,597 drugs and 3,391 conditions by eHealthMe. Currently, we are studying 258,035 people who have Hair loss.
Number of Orencia and Hair loss reports submitted per year:
Time on Orencia when people have Hair loss *:
Gender of people who have Hair loss when taking Orencia*:
Age of people who have Hair loss when taking Orencia *:
Common drugs people take besides Orencia *:
Common side effects people have besides Hair loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Orencia and have Hair loss?
Check whether Hair loss is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Related studies
Orencia side effects by duration, gender and age:
- Orencia side effects (125,317 reports)
Hair loss treatments and more:
- Hair loss (258,035 reports)
Common drugs associated with Hair loss:
- Taxotere: 34,064 reports
- Docetaxel: 25,062 reports
- Methotrexate: 19,713 reports
- Prednisone: 16,883 reports
- Humira: 14,833 reports
- Enbrel: 14,300 reports
- Remicade: 12,381 reports
- Neosar: 12,108 reports
- Orencia: 11,906 reports
- Simponi: 9,850 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,597 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 21,741 reports
- Multiple sclerosis: 14,215 reports
- Breast cancer: 11,443 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,391 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on abatacept (the active ingredients of Orencia) and Orencia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Adalat and Multihance drug interaction - 6 seconds ago
- Mestinon and Dexilant drug interaction - 8 seconds ago
- Adderall and Bortezomib drug interaction - 18 seconds ago
- Aranesp and Dermatitis - 20 seconds ago
- Honey and Calcium drug interaction - 26 seconds ago
- Testosterone Enanthate and Vitamin D drug interaction - 44 seconds ago
- Lorazepam and Graft Versus Host Disease - 49 seconds ago
- Lynparza and Meropenem drug interaction - 53 seconds ago
- Silybum Marianum and Naltrexone Hydrochloride drug interaction - 54 seconds ago
- Flovent Hfa and Paroxetine drug interaction - 59 seconds ago